Related Experiment Video
Updated: Aug 14, 2026
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
In vitro assays of substrate degradation induced by high-risk HPV E6 oncoproteins
Miranda Thomas1, Lawrence Banks
1Tumour Virology, International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
Abstract:
The high-risk mucosal human papillomavirus E6 proteins were the first viral proteins that were shown to use the ubiquitin proteasome pathway for the inactivation of their cellular target proteins. The first substrate to be identified was the p53 tumor suppressor protein, and since then many other substrates for E6-induced degradation have been described. All of these require the presence of high-risk mucosal E6 together with the E1, E2, and E3 enzymes of the ubiquitin pathway. This activity of E6, although complex, is nonetheless amenable to in vitro analysis. Many different protocols have been described over the years for performing these assays. In this chapter we describe the most easily used and robust procedure that is routinely used in our laboratory.
Insights
High-risk human papillomavirus E6 proteins target cellular proteins for degradation via the ubiquitin proteasome pathway. This study details a robust in vitro assay for analyzing E6-mediated protein inactivation.
Area of Science:
- Oncology
- Virology
- Molecular Biology
Background:
- High-risk mucosal human papillomavirus (HPV) E6 proteins are known to utilize the ubiquitin proteasome pathway.
- The p53 tumor suppressor protein was the first identified substrate for E6-induced degradation.
- Subsequent research has identified numerous other cellular targets for E6-mediated degradation.
Purpose of the Study:
- To describe a robust and easily used in vitro assay for analyzing the E6 protein's role in ubiquitin proteasome pathway-mediated protein degradation.
- To provide a standardized protocol for researchers studying E6-mediated substrate inactivation.
Main Methods:
- The study focuses on a specific, optimized in vitro assay protocol.
- The assay involves the high-risk mucosal E6 protein and ubiquitin pathway enzymes (E1, E2, E3).
- The protocol is designed for ease of use and reproducibility.
Main Results:
- The described in vitro assay is amenable to analyzing the complex activity of E6 proteins.
- The protocol is robust and routinely used in the laboratory.
- It facilitates the study of E6-induced degradation of cellular target proteins.
Conclusions:
- The presented in vitro assay provides a reliable method for studying E6-mediated protein degradation.
- This protocol can aid in understanding the mechanisms by which high-risk HPVs subvert cellular processes.
- Further research into E6-target interactions can be facilitated by this standardized assay.
